Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Opus Genetics, Inc. | Chief Financial Officer | Common Stock | 194K | $223K | $1.15 | Mar 13, 2025 | Direct |
Opus Genetics, Inc. | Chief Financial Officer | Employee Stock Option (right to buy) | 52.5K | Mar 13, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IRD | Opus Genetics, Inc. | Mar 13, 2025 | 2 | $0 | 4 | Mar 17, 2025 | Chief Financial Officer |
IRD | Opus Genetics, Inc. | Feb 13, 2025 | 1 | -$9.44K | 4 | Feb 18, 2025 | Chief Financial Officer |
OCUP | Ocuphire Pharma, Inc. | Mar 21, 2024 | 1 | $21K | 4 | Mar 25, 2024 | Chief Financial Officer |
OCUP | Ocuphire Pharma, Inc. | Feb 12, 2024 | 2 | $0 | 4 | Feb 14, 2024 | Chief Financial Officer |
OCUP | Ocuphire Pharma, Inc. | Feb 12, 2024 | 0 | $0 | 3 | Feb 14, 2024 | Chief Financial Officer |